Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.
about
Pharmacotherapy of type 2 diabetes mellitus.Protein kinase C activation and its pharmacological inhibition in vascular disease.Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosisDiabetes, hypertension, and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplantation survivor study.Serum leptin and its relation to anthropometric measures of obesity in pre-diabetic SaudisCardiovascular risk and risk reduction: a review of recent literatureInterleukin-6 receptor gene 48892 A/C polymorphism is associated with metabolic syndrome in female Taiwanese adolescents.Impaired glucose tolerance and unidentified diabetes.Post-transplant hyperlipidaemiaValidation of the Antidiabetic and Hypolipidemic Effects of Hawthorn by Assessment of Gluconeogenesis and Lipogenesis Related Genes and AMP-Activated Protein Kinase Phosphorylation.Dehydroeburicoic Acid from Antrodia camphorata Prevents the Diabetic and Dyslipidemic State via Modulation of Glucose Transporter 4, Peroxisome Proliferator-Activated Receptor α Expression and AMP-Activated Protein Kinase Phosphorylation in High-FatBiomarkers of the metabolic syndrome and breast cancer prognosis.Relationship of glycemic control, exogenous insulin, and C-peptide levels to ischemic heart disease mortality over a 16-year period in people with older-onset diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy (WESDR).Nutrigenomic Functions of PPARs in Obesogenic Environments.Cardiac and skeletal muscle insulin resistance in patients with coronary heart disease. A study with positron emission tomography.The role of hyperglycaemia and hyperinsulinaemia in causing vascular dysfunction in diabetes.Crocetin attenuates palmitate-induced insulin insensitivity and disordered tumor necrosis factor-alpha and adiponectin expression in rat adipocytes.How to transform a metabolic syndrome score into an insulin sensitivity value?Lercanidipine effect on polymorphonuclear leukocyte-related inflammation and insulin resistance in essential hypertension patientsLack of association of insulin resistance and carotid intimal medial thickness in non-diabetic Asian Indian subjects.Plasma leptin, fatty acids, and tumor necrosis factor-receptor and insulin resistance in children.Relation of leptin to insulin resistance syndrome in children.Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats.Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children.Momordica charantia ameliorates insulin resistance and dyslipidemia with altered hepatic glucose production and fatty acid synthesis and AMPK phosphorylation in high-fat-fed mice.Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo.A switch in the direction of the effect of insulin on the partitioning of hepatic fatty acids for the formation of secreted triacylglycerol occurs in vivo, as predicted from studies with perfused livers.Issues surrounding tight glycemic control in people with type 2 diabetes mellitus.
P2860
Q33992531-B8465027-77B9-4C82-BB90-390D0F139374Q34097328-CC413BAA-78D8-4E97-9567-C2EF47967D13Q34609585-6EAB8BCB-7115-432E-9CA9-1CA7DD472283Q35628840-11AE0C79-DCE7-4E0D-ABFF-17FD60A943D5Q35914633-E70BCBA9-1EC3-465D-8802-8F3F38C08E08Q36219177-BF4C1824-6500-450C-A664-9FEF16E07643Q36408096-1E4E26D1-3388-47CB-AD8F-1B2A52541480Q36680584-7A3BEBBC-D8B2-441A-8296-4D4699F4CE43Q36728201-CE599A0A-CBC7-43C7-A723-3C57F2D06522Q36838286-44D22BFF-F026-4D09-A36A-E15A66F11BCEQ37050630-2CA1F3D4-445A-4B45-A895-5E3B63EB6615Q37328339-E905B0FA-797F-4A6D-B0E3-260F0A0A72E4Q37412202-8A71E9F7-DF1F-4700-BB42-92D1D17FCAAAQ37500797-108FF1FD-13B9-4C54-B890-13BA251B3655Q39773232-CB96BE97-BAB9-4C65-9C73-BBE1A2E215F9Q41250366-E313FD86-425E-4E08-B86A-2624C51E0BEBQ41587620-57B30A6B-3436-4D86-A5F9-958F1514FA0DQ41641381-F55187FC-24F0-47D4-A27A-C0B3DC9FA463Q42744261-4E512FE4-80E6-4565-932D-BE565FDDC9C5Q43834019-2C99EB71-50B2-4B6F-8B43-F7EFF9EDF9B6Q44400046-9661638B-8C68-4932-A3A6-D06F248F8457Q44584075-ED8BFD3A-14F4-4A4A-8DCF-C6EAA9C4594CQ45199020-F0CCB645-AA64-4CD6-AF5A-359FDBFBF71DQ46843721-5E2F5D02-ED19-4A7B-9582-719DB74ED64FQ51050646-22B54175-3CDF-4384-9A47-FCA55FA02C0AQ51352273-53055A2C-D10D-48DF-8D1B-C8C28A126A6BQ51558281-2F257F33-3246-4CD3-AAAD-44DDC1FEDB07Q54122646-B8086009-3EE2-4285-B886-81A1857D3CCC
P2860
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.
@en
type
label
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.
@en
prefLabel
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.
@en
P356
P1433
P1476
Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease.
@en
P2093
P2888
P304
P356
10.1007/BF00400953
P577
1994-09-01T00:00:00Z